Back to Search
Start Over
United Therapeutics price target raised by $25 at Oppenheimer, here's why
- Source :
- The Fly. October 31, 2024
- Publication Year :
- 2024
-
Abstract
- Oppenheimer raised the firm's price target on United Therapeutics to $600 from $575 and keeps an Outperform rating on the shares following quarterly results. The firm says 'robust' Q3 financials [...]
- Subjects :
- Treprostinil
Business
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.814329772